See more : Cerence Inc. (0S6.DE) Income Statement Analysis – Financial Results
Complete financial analysis of Kali, Inc. (KALY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Kali, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- AMA Group Limited (AMA.AX) Income Statement Analysis – Financial Results
- Amarantus BioScience Holdings, Inc. (AMBS) Income Statement Analysis – Financial Results
- Suzhou Hycan Holdings Co., Ltd. (002787.SZ) Income Statement Analysis – Financial Results
- Scott’s Liquid Gold-Inc. (SLGD) Income Statement Analysis – Financial Results
- Visionstate Corp. (VIS.V) Income Statement Analysis – Financial Results
Kali, Inc. (KALY)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.kali-extracts.com
About Kali, Inc.
Kali, Inc., doing business as Kali-Extracts, Inc., engages in the research and development of cannabis treatments for various illnesses, diseases, and chronic pain as a symptom of various diagnoses. It provides pharmaceuticals, cannabis extracts, and health and wellness products. The company was formerly known as VLOV Inc. and changed its name to Kali, Inc. in February 2016. Kali, Inc. is based in Dallas, Texas.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 65.27K | 67.59K | 71.54K | 83.62K | 94.55M | 88.83M | 73.83M | 64.34M | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 50.90K | 48.95K | 70.19K | 0.00 | 52.49M | 50.06M | 43.86M | 41.08M | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 14.36K | 18.64K | 1.35K | 83.62K | 42.06M | 38.76M | 29.97M | 23.26M | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 22.01% | 27.58% | 1.89% | 100.00% | 44.48% | 43.64% | 40.59% | 36.15% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.27M | 5.47M | 4.06M | 5.09M | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 11.65M | 15.62M | 8.57M | 4.60M | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 26.27K | 27.95K | 0.00 | 88.75K | 17.91M | 21.09M | 12.62M | 9.69M | 66.05K | 65.31K | 10.59K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 26.27K | 27.95K | -3.00 | 88.75K | 17.91M | 21.09M | 12.62M | 9.69M | 66.05K | 65.46K | 10.59K |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 77.17K | 76.90K | 70.19K | 88.75K | 70.40M | 71.15M | 56.49M | 50.77M | 66.05K | 65.46K | 10.59K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 89.00K | 75.00K | 81.00K | 31.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.00K | 67.00K | 58.00K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 975.00K | 1.67M | 71.00K | 90.00K | 0.00 | 0.00 | 0.00 |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | -11.90K | -9.31K | 1.35K | -5.13K | 25.88M | 20.06M | 19.85M | 14.70M | -66.05K | -65.46K | -10.59K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -18.23% | -13.77% | 1.89% | -6.14% | 26.66% | 21.87% | 23.70% | 21.28% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | -11.90K | -9.31K | 1.35K | -5.13K | 24.14M | 17.68M | 17.35M | 13.57M | -66.05K | -65.46K | -10.59K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -18.23% | -13.77% | 1.89% | -6.14% | 25.54% | 19.90% | 23.49% | 21.09% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | -3.00 | 0.00 | 0.00 | 0.00 | 762.00K | 706.00K | 2.37M | 982.00K | 0.00 | -912.00 | -1.00 |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | -11.90K | -9.31K | 1.35K | -5.13K | 24.91M | 18.38M | 19.71M | 14.55M | -66.05K | -66.37K | -10.59K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -18.24% | -13.77% | 1.89% | -6.14% | 26.34% | 20.70% | 26.70% | 22.61% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 7.03M | 4.46M | 4.73M | 4.11M | 0.00 | 0.00 | 0.00 |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | -11.90K | -9.31K | 1.35K | -5.13K | 17.52M | 13.48M | 13.41M | 10.45M | -66.05K | -66.37K | -10.59K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | -18.24% | -13.77% | 1.89% | -6.14% | 18.53% | 15.17% | 18.17% | 16.23% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.83 | 5.42 | 5.79 | 4.93 | -4.44 | -4.90 | -0.79 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 6.78 | 5.36 | 5.79 | 4.91 | -4.44 | -4.90 | -0.79 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 1.02B | 587.24M | 285.13M | 13.85M | 2.57M | 2.49M | 2.32M | 2.12M | 14.88K | 13.55K | 13.33K |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 1.02B | 587.24M | 285.13M | 13.85M | 2.64M | 2.60M | 2.60M | 2.13M | 14.88K | 13.55K | 13.33K |
Source: https://incomestatements.info
Category: Stock Reports